These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 26662476)
1. Comparison between alcohol- and hepatitis C virus-related hepatocellular carcinoma: clinical presentation, treatment and outcome. Bucci L; Garuti F; Camelli V; Lenzi B; Farinati F; Giannini EG; Ciccarese F; Piscaglia F; Rapaccini GL; Di Marco M; Caturelli E; Zoli M; Borzio F; Sacco R; Maida M; Felder M; Morisco F; Gasbarrini A; Gemini S; Foschi FG; Missale G; Masotto A; Affronti A; Bernardi M; Trevisani F; ; Aliment Pharmacol Ther; 2016 Feb; 43(3):385-99. PubMed ID: 26662476 [TBL] [Abstract][Full Text] [Related]
2. Prognostic factors of survival in patients with non-resectable hepatocellular carcinoma: hepatitis C versus miscellaneous etiology. Abbas Z; Siddiqui AU; Luck NH; Hassan M; Mirza R; Naqvi A; Rizvi AH J Pak Med Assoc; 2008 Nov; 58(11):602-7. PubMed ID: 19024130 [TBL] [Abstract][Full Text] [Related]
3. Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma. Cabibbo G; Petta S; Barbara M; Attardo S; Bucci L; Farinati F; Giannini EG; Negrini G; Ciccarese F; Rapaccini GL; Di Marco M; Caturelli E; Zoli M; Borzio F; Sacco R; Virdone R; Marra F; Mega A; Morisco F; Benvegnù L; Gasbarrini A; Svegliati-Baroni G; Foschi FG; Olivani A; Masotto A; Nardone G; Colecchia A; Persico M; Craxì A; Trevisani F; Cammà C; J Hepatol; 2017 Jul; 67(1):65-71. PubMed ID: 28192185 [TBL] [Abstract][Full Text] [Related]
4. Prognosis of hepatocellular carcinoma in anti-HCV positive cirrhotic patients: a single-centre comparison amongst four different staging systems. Giannini E; Risso D; Botta F; Romagnoli P; Malfatti F; Fumagalli A; Testa E; Podestà E; Chiarbonello B; Polegato S; Testa R J Intern Med; 2004 Mar; 255(3):399-408. PubMed ID: 14871465 [TBL] [Abstract][Full Text] [Related]
5. Impact of etiology of cirrhosis on the survival of patients diagnosed with hepatocellular carcinoma during surveillance. Trevisani F; Magini G; Santi V; Morselli-Labate AM; Cantarini MC; Di Nolfo MA; Del Poggio P; Benvegnù L; Rapaccini G; Farinati F; Zoli M; Borzio F; Giannini EG; Caturelli E; Bernardi M; Am J Gastroenterol; 2007 May; 102(5):1022-31. PubMed ID: 17313497 [TBL] [Abstract][Full Text] [Related]
6. Impact of viral hepatitis aetiology on survival outcomes in hepatocellular carcinoma: A large multicentre cohort study. Mgaieth S; Kemp W; Gow P; Fink M; Lubel J; Nicoll A; Gazzola A; Hong T; Ryan M; Knight V; Dev AT; Sood S; Bell S; Paul E; Roberts SK J Viral Hepat; 2017 Nov; 24(11):982-989. PubMed ID: 28414893 [TBL] [Abstract][Full Text] [Related]
7. Hepatocellular carcinoma is diagnosed at a later stage in alcoholic patients: Results of a prospective, nationwide study. Costentin CE; Mourad A; Lahmek P; Causse X; Pariente A; Hagège H; Dobrin AS; Becker C; Marks B; Bader R; Condat B; Héluwaert F; Seitz JF; Lesgourgues B; Denis J; Deuffic-Burban S; Rosa I; Decaens T; Cancer; 2018 May; 124(9):1964-1972. PubMed ID: 29589878 [TBL] [Abstract][Full Text] [Related]
8. [Hepatocellular carcinoma in Germany. Epidemiology, etiology, clinical aspects and prognosis in 100 consecutive patients of a university clinic]. Petry W; Heintges T; Hensel F; Erhardt A; Wenning M; Niederau C; Häussinger D Z Gastroenterol; 1997 Dec; 35(12):1059-67. PubMed ID: 9487638 [TBL] [Abstract][Full Text] [Related]
9. Rise and fall of HCV-related hepatocellular carcinoma in Italy: a long-term survey from the ITA.LI.CA centres. Cazzagon N; Trevisani F; Maddalo G; Giacomin A; Vanin V; Pozzan C; Poggio PD; Rapaccini G; Nolfo AM; Benvegnù L; Zoli M; Borzio F; Giannini EG; Caturelli E; Chiaramonte M; Foschi FG; Cabibbo G; Felder M; Ciccarese F; Missale G; Baroni GS; Morisco F; Pecorelli A; Farinati F; Liver Int; 2013 Oct; 33(9):1420-7. PubMed ID: 23758775 [TBL] [Abstract][Full Text] [Related]
10. Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre. Grieco A; Pompili M; Caminiti G; Miele L; Covino M; Alfei B; Rapaccini GL; Gasbarrini G Gut; 2005 Mar; 54(3):411-8. PubMed ID: 15710992 [TBL] [Abstract][Full Text] [Related]
11. The value of the Barcelona Clinic Liver Cancer and alpha-fetoprotein in the prognosis of hepatocellular carcinoma. Gómez-Rodríguez R; Romero-Gutiérrez M; Artaza-Varasa T; González-Frutos C; Ciampi-Dopazo JJ; de-la-Cruz-Pérez G; Sánchez-Ruano JJ Rev Esp Enferm Dig; 2012 Jun; 104(6):298-304. PubMed ID: 22738699 [TBL] [Abstract][Full Text] [Related]
12. Trends in epidemiology, treatment, and survival of hepatocellular carcinoma patients between 1998 and 2009: an analysis of 1066 cases of a German HCC Registry. Weinmann A; Koch S; Niederle IM; Schulze-Bergkamen H; König J; Hoppe-Lotichius M; Hansen T; Pitton MB; Düber C; Otto G; Schuchmann M; Galle PR; Wörns MA J Clin Gastroenterol; 2014 Mar; 48(3):279-89. PubMed ID: 24045276 [TBL] [Abstract][Full Text] [Related]
13. Impact of hepatitis B and C virus infection on the clinical prognosis of alcoholic liver cirrhosis. Yamanaka T; Shiraki K; Nakazaawa S; Okano H; Ito T; Deguchi M; Takase K; Nakano T Anticancer Res; 2001; 21(4B):2937-40. PubMed ID: 11712790 [TBL] [Abstract][Full Text] [Related]
14. Favorable survival time provided with radioembolization in hepatocellular carcinoma patients with and without portal vein thrombosis. Ozkan ZG; Poyanli A; Ucar A; Kuyumcu S; Akyuz F; Keskin S; Saglam S; Yilmaz E; Karaca C; Turkmen C Cancer Biother Radiopharm; 2015 Apr; 30(3):132-8. PubMed ID: 25760644 [TBL] [Abstract][Full Text] [Related]
15. Comparison of outcomes between patients with alcoholic cirrhosis and those with hepatitis C virus-related cirrhosis. Toshikuni N; Izumi A; Nishino K; Inada N; Sakanoue R; Yamato R; Suehiro M; Kawanaka M; Yamada G J Gastroenterol Hepatol; 2009 Jul; 24(7):1276-83. PubMed ID: 19486451 [TBL] [Abstract][Full Text] [Related]
16. Rationality and effectiveness of transarterial chemoembolization as an initial treatment for BCLC B stage HBV-related hepatocellular carcinoma. Heng-jun G; Yao-jun Z; Min-shan C; Mei-xian C; Jun-ting H; Li X; Lau WY Liver Int; 2014 Apr; 34(4):612-20. PubMed ID: 24028297 [TBL] [Abstract][Full Text] [Related]
17. More advanced disease and worse survival in cryptogenic compared to viral hepatocellular carcinoma. Jun TW; Yeh ML; Yang JD; Chen VL; Nguyen P; Giama NH; Huang CF; Hsing AW; Dai CY; Huang JF; Chuang WL; Roberts LR; Yu ML; Nguyen MH Liver Int; 2018 May; 38(5):895-902. PubMed ID: 29045023 [TBL] [Abstract][Full Text] [Related]
18. External validation of the ITA.LI.CA prognostic system for patients with hepatocellular carcinoma: A multicenter cohort study. Borzio M; Dionigi E; Rossini A; Marignani M; Sacco R; De Sio I; Bertolini E; Francica G; Giacomin A; Parisi G; Vicari S; Toldi A; Salmi A; Boccia S; Mitra M; Fornari F Hepatology; 2018 Jun; 67(6):2215-2225. PubMed ID: 29165831 [TBL] [Abstract][Full Text] [Related]
19. Post-ablation des-gamma-carboxy prothrombin level predicts prognosis in hepatitis B-related hepatocellular carcinoma. Lee S; Rhim H; Kim YS; Kang TW; Song KD Liver Int; 2016 Apr; 36(4):580-7. PubMed ID: 26503910 [TBL] [Abstract][Full Text] [Related]
20. Ascites and alpha-fetoprotein improve prognostic performance of Barcelona Clinic Liver Cancer staging. Gomaa AI; Al-Khatib A; Abdel-Razek W; Hashim MS; Waked I World J Gastroenterol; 2015 May; 21(18):5654-62. PubMed ID: 25987792 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]